Phase 1 Fibrillation Clinical Trials
9 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–9 of 9 trials
Recruiting
Phase 1Phase 2
Anthocyanin-Rich Table Grape Powder for Prophylaxis of Post-Operative Atrial Fibrillation
Post-operative Atrial Fibrillation (POAF)
University of Michigan70 enrolled1 locationNCT05991700
Recruiting
Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
CancerAtrial FibrillationThrombosis+1 more
Massachusetts General Hospital165 enrolled1 locationNCT03830320
Recruiting
Phase 1Phase 2
Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects
Atrial Fibrillation, Postoperative
Helios Cardio Inc.80 enrolled1 locationNCT06730828
Recruiting
Phase 1
Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patients With Structural Heart Disease
Atrial Fibrillation
Assiut University100 enrolled1 locationNCT06556732
Recruiting
Phase 1
Synaptic Plasticity in the Epicardial Ganglionated Plexi
Atrial Fibrillation
University of Oklahoma90 enrolled1 locationNCT05034419
Completed
Phase 1
A Phase 1, Open-Label, Randomized, Single Dose Study of Flecainide Acetate Inhalation Solution (FlecIH-103) to Flecainide Acetate Intravenous Infusion (Tambocor®) to Compare Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
Atrial Fibrillation
InCarda Therapeutics Australia Pty Ltd.18 enrolled1 locationACTRN12621000718842
Recruiting
Phase 1
A Study of Safety, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Oral Doses of VE-01902 in Healthy Volunteers
Atrial Fibrillation
VCR1134 enrolled1 locationACTRN12618001509257
Completed
Phase 1
A Phase 1, Double-Blind, Randomized, Placebo-controlled, Single Ascending Dose Study of Flecainide Acetate Inhalation Solution to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
Recent Onset Paroxsymal Atrial Fibrillation
InCarda Therapeutics Australia44 enrolled1 locationACTRN12616001156471
Suspended
Phase 1
Placebo-Controlled, Single and Multiple Ascending Dose Study of BMS-919373 in Healthy Subjects.
Atrial Fibrillation
Bristol-Myers Squibb88 enrolled1 locationACTRN12611000373976